Chemoinformaics analysis of 32-Methyltetratriacontan-8-ol
| Molecular Weight | 508.96 | nRot | 31 |
| Heavy Atom Molecular Weight | 436.384 | nRig | 0 |
| Exact Molecular Weight | 508.558 | nRing | 0 |
| Solubility: LogS | -7.831 | nHRing | 0 |
| Solubility: LogP | 14.03 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 108 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 72 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 107.261 |
| nHD | 1 | BPOL | 72.2309 |
| QED | 0.092 |
| Synth | 2.751 |
| Natural Product Likeliness | 0.524 |
| NR-PPAR-gamma | 0.074 |
| Lipinski | Rejected |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.004 |
| HIA | 0.004 |
| CACO-2 | -5.347 |
| MDCK | 0.00000269 |
| BBB | 0.001 |
| PPB | 1.01703 |
| VDSS | 3.766 |
| FU | 0.00593176 |
| CYP1A2-inh | 0.027 |
| CYP1A2-sub | 0.118 |
| CYP2c19-inh | 0.081 |
| CYP2c19-sub | 0.05 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.97 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.008 |
| CYP3a4-inh | 0.117 |
| CYP3a4-sub | 0.009 |
| CL | 4.925 |
| T12 | 0.005 |
| hERG | 0.515 |
| Ames | 0.004 |
| ROA | 0.002 |
| SkinSen | 0.984 |
| Carcinogencity | 0.009 |
| EI | 0.915 |
| Respiratory | 0.115 |
| NR-Aromatase | 0.068 |
| Antiviral | No |
| Prediction | 0.593018 |